FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used in chemotherapeutic treatment of locally advanced and general breast cancer. It is ensured by autoplasmochemotherapy. Every time before introduction of cytostatic agents incubated with autoplasma, Trental is introduced intravenously drop-by-drop in a dose 100 mg dissolved in physiologic saline 200 ml.
EFFECT: method improves clinical effectiveness and reduces toxicity of autoplasmochemotherapy due to potentiation of anticancer action of chemoprepatations and protection of blood and bone marrow cells.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD OF NEOADJUVANT CHEMOTHERAPY OF MAMMARY GLAND CANCER | 2007 |
|
RU2338545C1 |
METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438659C1 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438675C1 |
METHOD TO TREAT MAMMARY GLAND CANCER | 2000 |
|
RU2178294C2 |
METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
METHOD FOR TREATMENT OF ABDOMINAL CAVITY PRIMARY AND METASTATIC TUMORS | 2003 |
|
RU2272655C2 |
METHOD FOR TREATING MAMMALIAN GLAND CARCINOMA | 1998 |
|
RU2158588C2 |
Authors
Dates
2009-11-20—Published
2008-05-12—Filed